Transactions
Aptus Clinical acquired by Catalyst Clinical Research
Apr. 2022
Client: Aptus Clinical is a full-service CRO with deep expertise in cutting-edge advanced therapies, such as cell and gene therapy, as well as in oncology and rare and orphan diseases
Role: Edgemont Partners acted as exclusive financial advisor to Aptus Clinical in its sale to Catalyst Clinical Research, a portfolio company of NovaQuest
Location: Macclesfield, UK
Sector: Pharmaceutical Services
Lead Banker: Andrew Karlin
acquired by
